This company has been marked as potentially delisted and may not be actively trading. Opiant Pharmaceuticals (OPNT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Opiant Pharmaceuticals Short Interest DataOpiant Pharmaceuticals (OPNT) has a short interest of 40,900 shares. This marks a 3.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 77,920 shares to cover all short positions.Current Short Interest40,900 sharesPrevious Short Interest39,400 sharesChange Vs. Previous Month+3.81%Dollar Volume Sold Short$858.49 thousandShort Interest Ratio0.5 Days to CoverLast Record DateFebruary 15, 2023Outstanding Shares5,270,000 sharesPercentage of Shares Shorted0.78%Today's Trading Volume562,700 sharesAverage Trading Volume77,920 sharesToday's Volume Vs. Average722% Short Selling Opiant Pharmaceuticals? Sign up to receive the latest short interest report for Opiant Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPNT Short Interest Over TimeOPNT Days to Cover Over TimeOPNT Percentage of Float Shorted Over Time Opiant Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202340,900 shares $858.49 thousand +3.8%N/A0.5 $20.99 1/31/202339,400 shares $795.09 thousand +41.7%N/A0.3 $20.18 1/15/202327,800 shares $563.23 thousand -6.4%N/A0.3 $20.26 12/30/202229,700 shares $602.32 thousand -3.3%N/A0.3 $20.28 12/15/202230,700 shares $621.06 thousand +153.7%N/A0.4 $20.23 11/30/202212,100 shares $243.45 thousand -25.3%N/A0.2 $20.12 11/15/202216,200 shares $326.92 thousand +13.3%N/A0.3 $20.18 10/31/202214,300 shares $136.28 thousand -26.3%N/A1 $9.53 10/15/202219,400 shares $191.28 thousand -24.2%N/A1.4 $9.86 9/30/202225,600 shares $275.20 thousand +23.1%N/A1.6 $10.75 Get the Latest News and Ratings for OPNT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Opiant Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/202220,800 shares $230.05 thousand -1.9%N/A1.3 $11.06 8/31/202221,200 shares $254.19 thousand -35.4%N/A1.2 $11.99 8/15/202232,800 shares $420.17 thousand -0.3%N/A1.4 $12.81 7/31/202232,900 shares $337.88 thousand -31.9%N/A0.7 $10.27 7/15/202248,300 shares $531.30 thousand +31.6%N/A0.6 $11.00 6/30/202236,700 shares $440.03 thousand -4.7%N/A0.4 $11.99 6/15/202238,500 shares $438.52 thousand -32.3%N/A0.4 $11.39 5/31/202256,900 shares $771.56 thousand -32.6%N/A0.6 $13.56 5/15/202284,400 shares $1.05 million +27.1%N/A0.8 $12.47 4/30/202266,400 shares $1.33 million +38.6%N/A0.7 $19.96 4/15/202247,900 shares $1.09 million +68.1%N/A0.8 $22.66 3/31/202228,500 shares $610.47 thousand +12.2%N/A0.4 $21.42 3/15/202225,400 shares $640.08 thousand -12.7%0.6%0.4 $25.20 2/28/202229,100 shares $761.26 thousand -1.0%0.7%0.4 $26.16 2/15/202229,400 shares $840.84 thousand +24.1%0.7%0.4 $28.60 1/31/202223,700 shares $592.26 thousand -17.1%0.6%0.4 $24.99 1/15/202228,600 shares $774.20 thousand +5.5%0.7%0.5 $27.07 12/31/202127,100 shares $911.37 thousand +0.7%0.6%0.5 $33.63 12/15/202126,900 shares $907.07 thousand +67.1%N/A0.4 $33.72 11/30/202116,100 shares $392.68 thousand -34.0%N/A0.2 $24.39 11/15/202124,400 shares $622.20 thousand +25.8%N/A0.4 $25.50 10/29/202119,400 shares $457.26 thousand -41.7%0.5%0.4 $23.57 10/15/202133,300 shares $762.24 thousand +48.0%0.8%0.6 $22.89 9/30/202122,500 shares $579.15 thousand +25.7%0.6%0.4 $25.74 9/15/202117,900 shares $390.22 thousand -21.2%0.4%0.1 $21.80 8/31/202122,700 shares $394.30 thousand +39.3%0.6%0.2 $17.37 8/13/202116,300 shares $252.32 thousand +15.6%0.4%0.1 $15.48 7/30/202114,100 shares $227.29 thousand -67.4%0.4%0.1 $16.12 7/15/202143,300 shares $690.20 thousand +220.7%1.1%0.3 $15.94 6/30/202113,500 shares $180.50 thousand -7.5%0.3%0.1 $13.37Utah’s New Oil Find (Ad)The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.Find out why this could be the most lucrative "underground" energy story in America 6/15/202114,600 shares $194.18 thousand -31.8%0.4%0.8 $13.30 5/28/202121,400 shares $270.71 thousand -4.9%0.5%1.2 $12.65 5/14/202122,500 shares $279 thousand -14.1%0.6%1 $12.40 4/30/202126,200 shares $323.05 thousand +35.8%0.7%0.9 $12.33 4/15/202119,300 shares $207.67 thousand +9.0%0.5%0.5 $10.76 3/31/202117,700 shares $187.97 thousand +45.1%0.5%0.4 $10.62 3/15/202112,200 shares $144.94 thousand +13.0%0.3%0.3 $11.88 2/26/202110,800 shares $140.72 thousand +6.9%0.3%0.2 $13.03 2/12/202110,100 shares $140.09 thousand +57.8%0.3%0.1 $13.87 1/29/20216,400 shares $72 thousand No Change0.2%0.1 $11.25 1/15/20216,400 shares $55.62 thousand -30.4%0.2%0.1 $8.69 12/31/20209,200 shares $74.28 thousand +55.9%0.2%0.2 $8.07 12/15/20205,900 shares $49.97 thousand -50.0%0.2%0.1 $8.47 11/30/202011,800 shares $99.95 thousand +118.5%0.3%0.5 $8.47 11/15/20205,400 shares $42.07 thousand +42.1%0.1%0.2 $7.79 10/30/20203,800 shares $26.73 thousand -35.6%0.1%0.2 $7.04 10/15/20205,900 shares $45.55 thousand -24.4%0.2%0.3 $7.72 9/30/20207,800 shares $58.34 thousand -32.8%0.2%0.3 $7.48 9/15/202011,600 shares $102.08 thousand +10.5%0.3%0.4 $8.80 8/31/202010,500 shares $91.25 thousand -29.5%0.3%0.2 $8.69 8/14/202014,900 shares $134.99 thousand +46.1%0.4%0.2 $9.06 7/31/202010,200 shares $93.64 thousand +7.4%0.3%0.1 $9.18 7/15/20209,500 shares $90.63 thousand -14.4%0.2%0.1 $9.54 6/30/202011,100 shares $98.35 thousand -26.0%0.3%0.2 $8.86 OPNT Short Interest - Frequently Asked Questions What is Opiant Pharmaceuticals' current short interest? Short interest is the volume of Opiant Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 40,900 shares of OPNT short. Learn More on Opiant Pharmaceuticals' current short interest. Is Opiant Pharmaceuticals' short interest increasing or decreasing? Opiant Pharmaceuticals saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 40,900 shares, an increase of 3.8% from the previous total of 39,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Opiant Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Opiant Pharmaceuticals: Mereo BioPharma Group plc (5.66%), Eton Pharmaceuticals, Inc. (3.51%), Savara Inc (23.19%), Kamada Ltd. (0.16%), Rigel Pharmaceuticals, Inc. (11.46%), Fulcrum Therapeutics, Inc. (10.98%), Revance Therapeutics, Inc. (4.32%), Rezolute, Inc. (8.97%), Checkpoint Therapeutics, Inc. (6.19%), ADC Therapeutics SA (4.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc ($4.09 billion), Occidental Petroleum Corporation ($3.00 billion), T. Rowe Price Group, Inc. ($2.35 billion), Coinbase Global, Inc. ($2.30 billion), Paramount Global ($2.04 billion), Etsy, Inc. ($1.90 billion), Voya Financial, Inc. ($1.77 billion), CarMax, Inc. ($1.67 billion), Royal Caribbean Cruises Ltd. ($1.58 billion), and Monolithic Power Systems, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Opiant Pharmaceuticals stock? Short selling OPNT is an investing strategy that aims to generate trading profit from Opiant Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Opiant Pharmaceuticals? A short squeeze for Opiant Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPNT, which in turn drives the price of the stock up even further. How often is Opiant Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPNT, twice per month. The most recent reporting period available is February, 15 2023. More Short Interest Resources from MarketBeat Related Companies Mereo BioPharma Group Short Interest Eton Pharmaceuticals Short Interest Savara Short Interest Kamada Short Interest Rigel Pharmaceuticals Short Interest Fulcrum Therapeutics Short Interest Revance Therapeutics Short Interest Rezolute Short Interest Checkpoint Therapeutics Short Interest ADC Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPNT) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opiant Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opiant Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
